The activity of hematopoietic stem cell transplantation in Korea
| Autor: | Chun-Choo Kim, Junguee Lee |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Transplantation
medicine.medical_specialty Acute leukemia Korea business.industry Rapid expansion Histocompatibility Testing medicine.medical_treatment Hematopoietic Stem Cell Transplantation Hematology Hematopoietic stem cell transplantation medicine.disease Severe Aplastic Anemia Tissue Donors Lymphoma surgical procedures operative immune system diseases Unrelated Donor hemic and lymphatic diseases Internal medicine Immunology medicine Humans Aplastic anemia business |
| Zdroj: | Bone Marrow Transplantation. 42:S92-S95 |
| ISSN: | 1476-5365 0268-3369 |
| Popis: | Since the first successful allogeneic hematopoietic SCT (HSCT) was performed in Korea in 1983, there has been a noticeable progress in both the quantity and quality of HSCT over 24 years. There are 38 HSCT centers in Korea and the number of both allogeneic and autologous HSCTs has been increasing every year. As of December 2006, a total of 9561 HSCTs have been carried out in Korea, including 5617 allogeneic (59%) and 3944 autologous HSCTs (41%). The main indications were acute leukemia (3979, 78% allogeneic); lymphoma (1244, 90% autologous); myeloma (939, 92% autologous) and aplastic anemia (938). Characteristically, severe aplastic anemia accounts for a considerable proportion of transplants (10%), compared with western countries. Recently, there has been a marked increase in the number of unrelated transplants and the usage of PBSCs. The pattern of infectious diseases associated with HSCT is quite different. The rapid expansion of unrelated donor pools worldwide has changed the outlook of an unrelated donor search in Korea. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|